THINGS THE ENT RESIDENTS WANT YOU TO KNOW

  • Slides: 58
Download presentation
THINGS THE ENT RESIDENTS WANT YOU TO KNOW ANDREA ZIEGLER PGY-5 8/16/2019

THINGS THE ENT RESIDENTS WANT YOU TO KNOW ANDREA ZIEGLER PGY-5 8/16/2019

OUTLINE Tracheotomy Laryngectomy Epistaxis Angioedema Acute Invasive Fungal Sinusitis Mastoid effusions vs mastoiditis

OUTLINE Tracheotomy Laryngectomy Epistaxis Angioedema Acute Invasive Fungal Sinusitis Mastoid effusions vs mastoiditis

ANATOMY Cricothyroidotomy – emergent Tracheotomy Open vs percutaneous Awake

ANATOMY Cricothyroidotomy – emergent Tracheotomy Open vs percutaneous Awake

CRICOTHYROIDOTOMY • Emergent surgical airway needed, and tracheostomy not possible • Risk of damage

CRICOTHYROIDOTOMY • Emergent surgical airway needed, and tracheostomy not possible • Risk of damage to subglottis • Relative CI: peds < 12 yo, infected larynx, laryngeal cancer, laryngeal trauma • Revise early to avoid subglottic stenosis

INDICATIONS FOR TRACHEOSTOMY Prolonged ventilator support Pulmonary toilet Obstruction Tumors Inflammation/edema Stenosis Trauma

INDICATIONS FOR TRACHEOSTOMY Prolonged ventilator support Pulmonary toilet Obstruction Tumors Inflammation/edema Stenosis Trauma

PROLONGED RESPIRATORY SUPPORT • Rationale • 7 -10 days of intubation typically acceptable •

PROLONGED RESPIRATORY SUPPORT • Rationale • 7 -10 days of intubation typically acceptable • Complications associated w/ longer intubation • Capillary perfusion pressure ≈ 30 cm H 2 O • Subglottis most susceptible (cricoid = complete ring) • Benefits • Lower sedation requirements • Ventilator weaning • Trach collar trials vs. re-intubation • Better pulmonary toilet

 In adult patients with prolonged ventilation, early tracheostomy (within 7 -14 days), is

In adult patients with prolonged ventilation, early tracheostomy (within 7 -14 days), is associated with significant reduction in hospital acquired pneumonia, incidence of mortality, duration of mechanical ventilation, and length of stay in ICU

TRACHEOSTOMY CONSULTS • No imminent extubation or withdrawal of care • Preferences • Anticoagulants

TRACHEOSTOMY CONSULTS • No imminent extubation or withdrawal of care • Preferences • Anticoagulants that can be held • No vasopressors/stable vasopressor requirements • Fi. O 2 ~ 40% • Family/patient discussion

OPEN TRACHEOSTOMY

OPEN TRACHEOSTOMY

PERCUTANEOUS TRACHEOSTOMY • Less time, less expensive, bedside • Bronchoscopy required • Contraindications •

PERCUTANEOUS TRACHEOSTOMY • Less time, less expensive, bedside • Bronchoscopy required • Contraindications • • • Enlarged thyroid Previous neck surgery Obesity Calcified tracheal rings Non-intubated Pediatric patient (relative)

PERCUTANEOUS VS OPEN? No significant difference in minor or major complications Cadaver studies show

PERCUTANEOUS VS OPEN? No significant difference in minor or major complications Cadaver studies show significantly more mucosal and cartilage damage in percutaneous group Could translate to increased risk of subglottis stenosis and difficult decannulation but has not been shown in studies

POSTOPERATIVE CXR? • Used to be performed for all trachs, now done only •

POSTOPERATIVE CXR? • Used to be performed for all trachs, now done only • • in specific situations Emergent procedure Pediatric patients Displaced tube Suspected PTX

PARTS OF A TRACH Obturator Inner cannula Cuffed trach Reading the faceplate Brand (Shiley,

PARTS OF A TRACH Obturator Inner cannula Cuffed trach Reading the faceplate Brand (Shiley, Portex, Bivona) Size (4, 6, 8) Type DCT = cuffed CFS= cuffless

SPECIAL TRACHS

SPECIAL TRACHS

POSTOPERATIVE ORDERS • • • Extra tube to bedside Suction q 1 hrs and

POSTOPERATIVE ORDERS • • • Extra tube to bedside Suction q 1 hrs and PRN Tape obturator above bed “Patient is neck breather” Clean/change inner cannula q 8 hrs and PRN

EARLY COMPLICATIONS • Tube obstruction (mucous plugs) • Humidification, frequent suctioning/irrigation • Accidental displacement/decannulation

EARLY COMPLICATIONS • Tube obstruction (mucous plugs) • Humidification, frequent suctioning/irrigation • Accidental displacement/decannulation • Recognition and replacement • Post-obstructive pulmonary edema • Mechanical ventilation, PEEP, diuretics • Tracheitis • Regular trach changes, Ciprofloxacin

FALSE PASSAGE

FALSE PASSAGE

DIFFICULTY VENTILATING • Call ENT • Assess tube patency: • Remove and replace inner

DIFFICULTY VENTILATING • Call ENT • Assess tube patency: • Remove and replace inner cannula, suction • Check return volumes, auscultate chest • 100% oxygen • Bag mask • Deflate cuff • Bedside scope • False tract or decannulation • <5 days – caution • >5 days – attempt to replace • Endotracheal intubation

LONG TERM COMPLICATIONS • Stenosis • Goal cuff pressures < 25 cm H 2

LONG TERM COMPLICATIONS • Stenosis • Goal cuff pressures < 25 cm H 2 O • Allow slight air leak or no cuff in kids • Granulation tissue • Bleeding • <48 h: usually incision • >48 h: r/o tracheoinnominate fistula (TIF) • Tracheocutaneous fistula (post-decannulation)

TRACHEOINNOMINATE FISTULA • “Sentinel Bleed” • CT angiogram neck and chest • 60% within

TRACHEOINNOMINATE FISTULA • “Sentinel Bleed” • CT angiogram neck and chest • 60% within 2 weeks • 70 -90% mortality • Causes • • Too low (below 3 rd ring) High cuff pressures Tube torsion/movement Local infection

MANAGEMENT OF TI FISTULA • • • ENT & Thoracic Surgery Overinflate cuff or…

MANAGEMENT OF TI FISTULA • • • ENT & Thoracic Surgery Overinflate cuff or… Pass ETT below level of bleed Compress innominate against sternum with finger anterior to trachea Definitive treatment: ligate innominate artery

VOICING AFTER A TRACH Passy Muir Valve One way valve – air in, but

VOICING AFTER A TRACH Passy Muir Valve One way valve – air in, but no air out Should not be used with cuffed trachs In head and neck cancer patients, higher rates of depression in patients with trach without a speaking valve

PO INTAKE AFTER TRACH • Many patients will aspirate on VFSS test with new

PO INTAKE AFTER TRACH • Many patients will aspirate on VFSS test with new tracheostomy • Often easier for patient to eat once trach is downsized or cuff is deflated • Decannulation, capping, or PMV should be attempted in patients w/ trach to help with aspiration • Speech pathology will help in rehabilitation

DECANNULATION • Original indication for trach resolved • Including no additional planned treatment or

DECANNULATION • Original indication for trach resolved • Including no additional planned treatment or procedures • No further need for aggressive pulmonary toilet • Capping trial • Decannulation • Tape (wound reinforcement) • Education (during speech, coughing) • Surgical closure for failures

PREVIOUSLY PLACED TRACHS If placed by another service, they should be notified first of

PREVIOUSLY PLACED TRACHS If placed by another service, they should be notified first of any issues and we are available to help Can evaluate previously placed trachs if having issues

LARYNGECTOMY • Permanent, COMPLETE separation of pharynx and trachea • Includes removal of entire

LARYNGECTOMY • Permanent, COMPLETE separation of pharynx and trachea • Includes removal of entire larynx and hyoid bone • Indicated for advanced laryngeal CA, poor pulmonary status/toilet, chronic aspiration (e. g. non-functional larynx)

LARYNGECTOMY

LARYNGECTOMY

LARYNGECTOMY PEARLS • Do not try to intubate through the mouth for any reason

LARYNGECTOMY PEARLS • Do not try to intubate through the mouth for any reason • Stomal intubation only • Humidification/trach collar (no nasal O 2) • Saline squirts • Suction (red rubber catheters) • These patients ARE NOT ASPIRATING

EPISTAXIS

EPISTAXIS

EPISTAXIS RISK FACTORS • • Dryness Hypertension Anticoagulation Trauma Coagulopathies Septal perforations Neoplasms •

EPISTAXIS RISK FACTORS • • Dryness Hypertension Anticoagulation Trauma Coagulopathies Septal perforations Neoplasms • Problem bleeds usually have underlying condition (anticoagulation, HHT, wegner’s, etc)

ANTERIOR VS POSTERIOR EPISTAXIS • 90% are anterior epistaxis • Kisselbach’s plexus • Presentation/exam

ANTERIOR VS POSTERIOR EPISTAXIS • 90% are anterior epistaxis • Kisselbach’s plexus • Presentation/exam • Posterior – may all be bleeding into posterior pharynx and being swallowed • Easily seen in posterior pharynx – will not have a significant epistaxis without clear evidence of bleeding

EPISTAXIS MANAGEMENT • Initial • Topical vasoconstriction (afrin) • Firm, bilateral pressure (at least

EPISTAXIS MANAGEMENT • Initial • Topical vasoconstriction (afrin) • Firm, bilateral pressure (at least 15 mins) • Refractory (ENT consult) • Cautery • Anterior pack – Merocel, rapid rhino, epistat • Hemostatic adjuncts – Surgicel®, Floseal • Posterior pack – ICU monitoring • Bradycardic and apneic reflex with stimulation of NP • Embolization, surgery (open v. endoscopic)

ADDITIONAL EPISTAXIS MANAGEMENT • Blood pressure • Coagulopathy • Fluid repletion • Transfusion •

ADDITIONAL EPISTAXIS MANAGEMENT • Blood pressure • Coagulopathy • Fluid repletion • Transfusion • Antibiotics (packing) • Nasal saline spray QID, Vaseline to septum BID, humidifier

REFRACTORY EPISTAXIS • Endoscopic or open ligation of vessels • Embolization • Cannot be

REFRACTORY EPISTAXIS • Endoscopic or open ligation of vessels • Embolization • Cannot be performed on anterior or posterior ethmoids

ANGIOEDEMA

ANGIOEDEMA

ANGIOEDEMA • Increased vascular permeability → swelling of deep dermis, subcutaneous or submucosal tissue

ANGIOEDEMA • Increased vascular permeability → swelling of deep dermis, subcutaneous or submucosal tissue • Watery edema of mucosa anywhere from lips to glottis • “skip lesions” • Laryngeal edema • Dysphagia, globus, dysphonia, stridor

ANGIOEDEMA ETIOLOGY • Allergic • True anaphylaxis: food, drugs • Ig. E-mediated mast cell

ANGIOEDEMA ETIOLOGY • Allergic • True anaphylaxis: food, drugs • Ig. E-mediated mast cell degranulation • Usually presents with urticaria/hives • Pseudoallergic • ASA and NSAID induced (COX inhibition → leukotriene overproduction) • Idiopathic • Exercise, cold, heat, anxiety/emotional stress • Non-Ig. E mediated mast cell degranulation, possibly autoimmune related

ANGIOEDEMA ETIOLOGY • Non-Allergic/drug induced: bradykinin mediated • ACE inhibitor-induced • Bradykinin = potent

ANGIOEDEMA ETIOLOGY • Non-Allergic/drug induced: bradykinin mediated • ACE inhibitor-induced • Bradykinin = potent vasodilator, inactivated by ACE • ACE-I → increased bradykinin levels • African-Americans 3. 0 -4. 5 RR • Hereditary angioedema • decreased C 1 inhibitor production • Acquired angioedema • C 1 inhibitor auto-antibodies

TREATMENT • Evaluate and secure airway, NPO in case need to secure airway in

TREATMENT • Evaluate and secure airway, NPO in case need to secure airway in the future • 0. 3 ml 1: 1, 000 IM or 0. 3 ml 1: 100, 000 IV epinephrine if acute life threatening • IV methylprednisolone (Solumedrol) 100 -125 mg IV once – works quickly • IV diphenhydramine • IV ranitidine or pepcid • IV decadron • FFP for hereditary type (contains C 1 inhibitor)

ADDITIONAL TREATMENT FOR HEREDITARY ANGIOEDEMA Berinert, ruconest (~$3, 000 -6, 000)– C 1 inhibitor

ADDITIONAL TREATMENT FOR HEREDITARY ANGIOEDEMA Berinert, ruconest (~$3, 000 -6, 000)– C 1 inhibitor Firazyr (Icatibant ~$10, 000) – B 2 bradykinin receptor antagonist Kalbitor (Ecallantide ~$15, 000)– kallikrein inhibitor Cinryze, Takhzyro, Haegarda – prophylaxis

TREATMENT Gen med obs for minor oral cavity involvement MICU for severe or laryngeal

TREATMENT Gen med obs for minor oral cavity involvement MICU for severe or laryngeal involvement Serial exams – look for improvement, not necessarily resolution before starting PO +/- steroid taper Allergy referral for recurrent episodes

INVASIVE FUNGAL SINUSITIS

INVASIVE FUNGAL SINUSITIS

INVASIVE FUNGAL SINUSITIS • No risk to immuno-competent host, always in immunocompromised • Characterized

INVASIVE FUNGAL SINUSITIS • No risk to immuno-competent host, always in immunocompromised • Characterized by fungal angioinvasion → ischemia and necrosis • Rapid tissue destruction • High mortality even with treatment (up to 50%)

INVASIVE FUNGAL SINUSITIS • Invasive fungal infections • Aspergillus (hematologic malignancy), Mucormycosis (DKA), Rhizopus

INVASIVE FUNGAL SINUSITIS • Invasive fungal infections • Aspergillus (hematologic malignancy), Mucormycosis (DKA), Rhizopus • Five major forms • • Rhinocerebral 44 -49% Cutaneous 10 -16% Pulmonary 10 -11% Disseminated 6 -11% • Two or more noncontiguous sites • Mortality near 100%

RISK FACTORS • • • Diabetes with metabolic acidosis High-dose systemic corticosteroids Patients w/

RISK FACTORS • • • Diabetes with metabolic acidosis High-dose systemic corticosteroids Patients w/ hematologic malignancy/transplantation Solid-organ transplantation Neutropenia AIDS

SYMPTOMS OF INVASIVE FUNGAL SINUSITIS Fever Facial pressure or pain Headache Nasal congestion and

SYMPTOMS OF INVASIVE FUNGAL SINUSITIS Fever Facial pressure or pain Headache Nasal congestion and rhinorrhea Facial numbness Proptosis

DIAGNOSIS Exam Ischemia/Necrosis Insensate Don’t forget oral cavity exam Cranial neuropathies

DIAGNOSIS Exam Ischemia/Necrosis Insensate Don’t forget oral cavity exam Cranial neuropathies

DIAGNOSIS Nasal Endoscopy No topical anesthesia so can assess sensation Pale insensate mucosa >

DIAGNOSIS Nasal Endoscopy No topical anesthesia so can assess sensation Pale insensate mucosa > ischemia Black mucosa > necrosis +/- biopsy

IMAGING MRI vs CT Non specific findings Early disease limited to mucosa often undetectable

IMAGING MRI vs CT Non specific findings Early disease limited to mucosa often undetectable on imaging Should not delay treatment if high concern after endoscopy May see mucosal thickening with soft tissue invasion, bony erosion with advanced disease

TREATMENT Reversal of underlying condition when possible Tight glycemic control Normalize acidosis Hold steroids

TREATMENT Reversal of underlying condition when possible Tight glycemic control Normalize acidosis Hold steroids and immunosuppressants when able Urgent/emergent debridement Systemic antifungals

MASTOID EFFUSIONS VS MASTOIDITIS

MASTOID EFFUSIONS VS MASTOIDITIS

ACUTE COALESCENT MASTOIDITIS Tenderness of mastoid Proptosis of ear Fever *Erosion of bony septations

ACUTE COALESCENT MASTOIDITIS Tenderness of mastoid Proptosis of ear Fever *Erosion of bony septations of mastoid or subperiosteal abscess This is rare

INCIDENTAL MASTOID EFFUSIONS OR “OTOMASTOIDITIS” Majority of intubated patients will have some fluid in

INCIDENTAL MASTOID EFFUSIONS OR “OTOMASTOIDITIS” Majority of intubated patients will have some fluid in mastoid Not indicative of infection, not a risk for infection

CALLING ENT CONSULTS Be patient with us and our OR nurses! We don’t have

CALLING ENT CONSULTS Be patient with us and our OR nurses! We don’t have a true ”consult” resident. We will see emergencies when needed but please help us triage what can wait until later.

QUESTIONS?

QUESTIONS?